Postprandial plasma incretin hormones in exercise-trained versus untrained subjects

Medicine and Science in Sports and Exercise

Volumn 46, Issue 6, 2014, Pages 1098-1103

  Weiss, Edward P ^a,b   Royer, Nathaniel K ^a   Fisher, Jonathan S ^a   Holloszy, John O ^b   Fontana, Luigi ^b,c,d  

^a SAINT LOUIS UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SALERNO   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE TOLERANCE; GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE; INSULIN SENSITIVITY

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; INCRETIN; INSULIN;

ANTHROPOMETRY; AREA UNDER THE CURVE; BLOOD; CALORIC INTAKE; CROSS-SECTIONAL STUDY; ENDURANCE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL EDUCATION; PHYSIOLOGY; POSTPRANDIAL STATE;

ANTHROPOMETRY; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; ENERGY INTAKE; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; INCRETINS; INSULIN; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL EDUCATION AND TRAINING; PHYSICAL ENDURANCE; POSTPRANDIAL PERIOD;

EID: 84901377862     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000204     Document Type: Article

References (26)

1. Adam TC, Jocken J, Westerterp-Plantenga MS. Decreased glucagonlike peptide 1 release after weight loss in overweight/obese subjects. Obes Res. 2005;13(4):710-6.
2. Adam TC, LejeuneMP,Westerterp-PlantengaMS. Nutrient-stimulated glucagon-like peptide 1 release after body-weight loss and weight maintenance in human subjects. Br J Nutr. 2006;95(1):160-7.
3. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care. 1995;18(2):245-50.
4. Dela F, Mikines KJ, Tronier B, Galbo H. Diminished argininestimulated insulin secretion in trained men. J Appl Physiol. 1990; 69(1):261-7.
5. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr). 2010;32(1):97-108.
6. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A. 2004;101(17):6659-63.
7. Fukase N, Igarashi M, Takahashi H, et al. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med. 1993;10(1):44-9.
8. Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol. 2005;99(1):338-43.
9. Jones IR, Owens DR, Luzio SD, Hayes TM. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss. Diabete Metab. 1989;15(1):11-22.
10. Kelly KR, Brooks LM, Solomon TP, Kashyap SR, O'Leary VB, Kirwan JP. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab. 2009;296(6):E1269-74.
11. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60-to 70-year-old men and women. J Gerontol. 1993;48(3):M84-90.
12. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet. 1987;2 (8571):1300-4.
13. Krotkiewski M, Bjorntorp P, Holm G, et al. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects. Int J Obes. 1984;8(3):193-9.
14. Malin SK, Huang H, Muyla A, Kashyap SR, Kirwan JP. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome. Peptides. 2013;47:142-7.
15. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-70.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
17. Morgan DR, Lazarow A. Immunoassay of insulin: two antibody system. Diabetes. 1963;12:115-26.
18. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care. 2006;29(3):673-8.
19. Slentz CA, Tanner CJ, Bateman LA, et al. Effects of exercise training intensity on pancreatic beta-cell function. Diabetes Care. 2009;32(10):1807-11.
20. Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care. 2010;33(7):1561-6.
21. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001;25(8):1206-14.
22. Vilsboll T, Krarup T, Sonne J, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2003;88 (6):2706-13.
23. Weiss EP, Park JJ, McKenzie JA, et al. Plasma nitrate/nitrite response to an oral glucose load and the effect of endurance training. Metabolism. 2004;53(5):673-9.
24. Weiss EP, Racette SB, Villareal DT, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: A randomized controlled trial. Am J Clin Nutr. 2006;84(5):1033-42.
25. Weiss EP, Spina RJ, Holloszy JO, Ehsani AA. Gender differences in the decline in aerobic capacity and its physiological determinants during the later decades of life. J Appl Physiol. 2006;101(3):938-44.
26. Willms B, Ebert R, Creutzfeldt W. Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction. Diabetologia. 1978;14(6):379-87.